GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qilian International Holding Group Ltd (NAS:QLI) » Definitions » EV-to-EBITDA

Qilian International Holding Group (Qilian International Holding Group) EV-to-EBITDA : -6.00 (As of May. 01, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Qilian International Holding Group EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Qilian International Holding Group's enterprise value is $7.65 Mil. Qilian International Holding Group's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was $-1.28 Mil. Therefore, Qilian International Holding Group's EV-to-EBITDA for today is -6.00.

The historical rank and industry rank for Qilian International Holding Group's EV-to-EBITDA or its related term are showing as below:

QLI' s EV-to-EBITDA Range Over the Past 10 Years
Min: -7.22   Med: 11.75   Max: 42.23
Current: -6

During the past 7 years, the highest EV-to-EBITDA of Qilian International Holding Group was 42.23. The lowest was -7.22. And the median was 11.75.

QLI's EV-to-EBITDA is ranked worse than
100% of 707 companies
in the Drug Manufacturers industry
Industry Median: 14.39 vs QLI: -6.00

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-01), Qilian International Holding Group's stock price is $0.734. Qilian International Holding Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.220. Therefore, Qilian International Holding Group's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Qilian International Holding Group EV-to-EBITDA Historical Data

The historical data trend for Qilian International Holding Group's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qilian International Holding Group EV-to-EBITDA Chart

Qilian International Holding Group Annual Data
Trend Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
EV-to-EBITDA
Get a 7-Day Free Trial - - 34.63 8.53 -6.17

Qilian International Holding Group Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.63 - 8.53 - -6.17

Competitive Comparison of Qilian International Holding Group's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Qilian International Holding Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qilian International Holding Group's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Qilian International Holding Group's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Qilian International Holding Group's EV-to-EBITDA falls into.



Qilian International Holding Group EV-to-EBITDA Calculation

Qilian International Holding Group's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=7.645/-1.275
=-6.00

Qilian International Holding Group's current Enterprise Value is $7.65 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Qilian International Holding Group's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was $-1.28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qilian International Holding Group  (NAS:QLI) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Qilian International Holding Group's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.734/-0.220
=At Loss

Qilian International Holding Group's share price for today is $0.734.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Qilian International Holding Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.220.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Qilian International Holding Group EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Qilian International Holding Group's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Qilian International Holding Group (Qilian International Holding Group) Business Description

Traded in Other Exchanges
N/A
Address
Jiuquan Economic and Technological Development Zone, Gansu Province, Jiuquan, CHN, 735000
Qilian International Holding Group Ltd is a pharmaceutical and chemical company. The company is engaged in the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives products, heparin products, sausage casings, and fertilizers. It operates through three segments namely, Oxytetracycline and Licorice products and TCMD; Fertilizer; and Heparin products and Sausage casing. Oxytetracycline and Licorice products and TCMD segment generates majority of the revenue.

Qilian International Holding Group (Qilian International Holding Group) Headlines

From GuruFocus